-
1 month ago | 
hcplive.com | Victoria Johnson |Thomas Casale
CommentaryVideoMarch 6, 2025Author(s):,Casale discussed data from the phase 3 LIBERTY-CSU CUPID studies evaluating dupilumab’s use in urticaria.
-
1 month ago | 
hcplive.com | Victoria Johnson |Thomas Casale
Briquilimab was well-tolerated and seemed to control disease in patients with chronic spontaneous urticaria (CSU) according to new data from the phase 1b/2a BEACON study (NCT06162728). These findings were presented at the 2025 American Academy of Allergy, Asthma, and Immunology/World Allergy Organization Joint Congress, February 28-March 3, in San Diego, California, by Thomas Casale, MD, Professor, Internal Medicine, Morsani College of Medicine, University of South Florida.
-
Jan 16, 2025 | 
hcplive.com | Victoria Johnson
NewsArticleJanuary 16, 2025Author(s):Heat therapy often worsened symptoms in a randomized controlled trial.
-
Jan 16, 2025 | 
hcplive.com | Victoria Johnson
New research has found that cyclic adenosine monophosphate (cAMP) is highly elevated in the blood of people with asthma, enabling diagnosis and possibly severity determination with a simple blood test.1 "What we discovered is a specific transporter, a protein on the membrane of airway smooth muscle cells, allows cAMP to leak into the blood," senior investigator Reynold Panettieri, MD, vice chancellor for Translational Medicine and Science at Rutgers University, said in a statement.2 "For...
-
Jan 15, 2025 | 
hcplive.com | Victoria Johnson
Biologic treatment for rheumatoid arthritis (RA) or psoriatic arthritis (PsA) did not negatively affect fertility in women, according to a recent study published by Elsevier in Seminars in Arthritis and Rheumatism.1 “Although used frequently, knowledge regarding the possible effects of bDMARDs on aspects of fertility remains limited… Women with RA have been reported to have fewer offspring than intended, experience prolonged time to conception, and have a higher incidence of sub-fertility...
-
Jan 15, 2025 | 
hcplive.com | Victoria Johnson
A virtual reality (VR) exergame to assist patients with fibromyalgia in performing physical activity was found to be feasible and may reduce depression, stress and anxiety, while boosting motivation and relaxation in both healthy participants and those with fibromyalgia.1“Exergames are video games that require physical exercise to progress, offering low-impact, controlled movements that can effectively distract players from pain.
-
Jan 14, 2025 | 
hcplive.com | Victoria Johnson
New research has found a large proportion of injurious falls, which were made more likely with high fall-risk increasing drug (FRID) burden, in adults with chronic obstructive pulmonary disease (COPD) near end of life.1“Fall-risk increasing drugs are commonly prescribed to people with COPD because they experience a high number of symptoms and conditions that indicate use of these drugs,” lead investigator Cara L.
-
Jan 14, 2025 | 
hcplive.com | Victoria Johnson
The US Preventive Services Task Force (USPSTF) has released its finalized recommendation statement on screening for osteoporosis to prevent fractures in adults 40 years or older without known osteoporosis or history of fragility fractures, largely preserving guidelines from its 2018 recommendations.1,2 Similarly to the 2018 recommendations, the USPSTF has given a B recommendation for screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older and for screening for...
-
Jan 13, 2025 | 
hcplive.com | Victoria Johnson
Most people with gout were able to achieve patient acceptable symptom state (PASS) or low disease activity (LDA) in the second 6 months after initiating allopurinol, and these disease state definitions aligned with gout flare burden on patients.1“…the majority of studies of urate-lowering therapies (ULTs) have used serum urate as a “surrogate” measure for gout flares.
-
Jan 12, 2025 | 
hcplive.com | Victoria Johnson
Patients with rheumatic diseases who received biologic disease- modifying anti-rheumatic drugs (bDMARDs) after a kidney transplant had a high risk of serious infections, according to new research published in Clinical Rheumatology.1“There is a significant knowledge gap regarding the adverse events associated with bDMARDs in rheumatic patients’ post-transplant, especially given their concurrent use of immunosuppressives to pre- vent kidney rejection.
